ivim tirzepatide shortage Lilly's weight-loss drug removed from FDA's list Eli Lilly's Weight-Loss, Diabetes Drug

PMID: 16032049

AC: Writing original draft, Supervision, Data curation

MRI changes in the volume of the ventricles and a composite region (hippocampus and entorhinal cortex) from baseline to 52 weeks were assessed in a predefined secondary analysis

Contact your GP or diabetes specialist nurse if you experience : Excessive thirst combined with frequent urination : This may indicate worsening glycaemic control or inadequate diabetes management, requiring blood glucose monitoring and potential treatment adjustment

Neither platform replaces individualized medical evaluation

Their individual cases have been centralized in a federal multi-district litigation (MDL) in the U.S